Winstrol – Stanozolol 20mg
Winstrol is presented in the ORYVION catalog as a tablet formulation containing 20mg of stanozolol per tablet, supplied in containers of 50 tablets. Stanozolol is an orally active synthetic steroid derived from dihydrotestosterone, with both anabolic and androgenic properties.
Its pharmacological profile includes anabolic activity alongside effects on androgen-sensitive tissues. Stanozolol has historically been used in medical settings for conditions including hereditary angioedema and aplastic anemia. Its effects also extend to reproductive function, liver health, and lipid metabolism.
Product Specifications:
Commercial name: Winstrol
Listed compound: Stanozolol
Declared strength: 20mg per tablet
Format: Tablets
Package contents: 50 tablets
Important Note:
Stanozolol can cause liver damage and adverse cholesterol changes associated with increased cardiovascular risk. Other concerns include acne, menstrual disturbances, testicular atrophy, and impaired sexual function. Psychiatric adverse effects may also occur.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.